Poor
Poorly Aligned
Patient Risk:
Low
Summary
All three claims are not supported by the provided labeling; the claims refer to decanoate and generic/copay aspects not addressed in the label sections supplied.
Category Scores
Accurate Statements
Unsupported Statements
Fluphenazine decanoate is an older antipsychotic injection.
Label sections provided discuss fluphenazine hydrochloride tablets (oral) and do not mention decanoate or any injectable formulation.
Fluphenazine decanoate is commonly available as a generic.
Label does not discuss generic status; no information about generic availability is present in the provided sections.
Generic products are often not eligible for manufacturer copay coupons.
Copay coupon eligibility is not addressed anywhere in the provided label sections.
Contradictions
Important Omissions
The label sections provided do not cover decanoate formulations, depot/injectable forms, generic status, or copay coupon eligibility; no related statements exist in the label excerpt.
Importance:
Moderate
Safety Assessment
Potential Patient Risk:
Low
Misalignment arises from non-labeled content; no patient safety data is directly implicated by the evaluated statements.
Regulatory Assessment
| On Label |
No |
| Off-label Discussion |
Yes |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Low |
Recommendation
Poorly Aligned
Primary Issue
All three claims are not supported by the provided label content; there is no mention of fluphenazine decanoate, generic status, or copay coupon considerations in the label excerpts.
Suggested Improvement
Restrict claims to information explicitly stated in the label; avoid extrapolating from related but non-labeled forms (e.g., decanoate) or external factors (e.g., coupons) not discussed in the label.